SG Americas Securities
IART icon

SG Americas Securities’s Integra LifeSciences IART Stock Holding History

SG Americas Securities’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.52M Buy
196,233
+65,679
+50% +$919K ﹤0.01% 1246
2026
Q1 		$1.23M Sell
130,554
-249,675
-66% -$2.74M ﹤0.01% 1624
2025
Q4 		$4.72M Buy
+380,229
New +$5.06M 0.01% 1116
2025
Q3 		– Sell
-8,719
Closed -$107K – 3462
2025
Q2 		$107K Buy
+8,719
New +$127K ﹤0.01% 2612
2024
Q4 		– Sell
-28,211
Closed -$513K – 3343
2024
Q3 		$513K Sell
28,211
-39,260
-58% -$910K ﹤0.01% 1669
2024
Q2 		$1.97M Buy
67,471
+57,927
+607% +$1.72M 0.01% 960
2024
Q1 		$338K Buy
9,544
+6,606
+225% +$264K ﹤0.01% 1622
2023
Q4 		$128K Sell
2,938
-12,506
-81% -$492K ﹤0.01% 2548
2023
Q3 		$590K Sell
15,444
-32,902
-68% -$1.38M 0.01% 1642
2023
Q2 		$1.99M Buy
48,346
+41,397
+596% +$1.99M 0.02% 742
2023
Q1 		$399K Sell
6,949
-10,631
-60% -$599K ﹤0.01% 1884
2022
Q4 		$986K Buy
17,580
+7,029
+67% +$358K 0.01% 983
2022
Q3 		$447K Sell
10,551
-18,119
-63% -$928K 0.01% 1644
2022
Q2 		$1.55M Buy
28,670
+21,616
+306% +$1.3M 0.02% 919
2022
Q1 		$453K Sell
7,054
-1,337
-16% -$88K ﹤0.01% 1951
2021
Q4 		$562K Sell
8,391
-6,752
-45% -$457K ﹤0.01% 2095
2021
Q3 		$1.04M Buy
15,143
+2,725
+22% +$193K ﹤0.01% 1876
2021
Q2 		$847K Buy
12,418
+1,262
+11% +$89.2K ﹤0.01% 1670
2021
Q1 		$771K Sell
11,156
-11,772
-51% -$798K ﹤0.01% 1713
2020
Q4 		$1.49M Buy
22,928
+6,992
+44% +$376K 0.01% 1283
2020
Q3 		$752K Sell
15,936
-3,926
-20% -$187K ﹤0.01% 1372
2020
Q2 		$933K Buy
+19,862
New +$976K 0.01% 1473
2020
Q1 		– Sell
-18,197
Closed -$1.06M – 3554
2019
Q4 		$1.06M Buy
18,197
+9,744
+115% +$580K 0.01% 1224
2019
Q3 		$508K Sell
8,453
-52,247
-86% -$3.11M ﹤0.01% 1878
2019
Q2 		$3.39M Buy
60,700
+53,277
+718% +$2.74M 0.02% 722
2019
Q1 		$414K Buy
7,423
+1,925
+35% +$98K ﹤0.01% 1991
2018
Q4 		$248K Sell
5,498
-14,968
-73% -$821K ﹤0.01% 2286
2018
Q3 		$1.35M Sell
20,466
-29,630
-59% -$1.84M 0.01% 1466
2018
Q2 		$3.23M Buy
50,096
+45,879
+1,088% +$2.84M 0.03% 643
2018
Q1 		$233K Sell
4,217
-10,027
-70% -$526K ﹤0.01% 2329
2017
Q4 		$682K Sell
14,244
-6,425
-31% -$314K 0.01% 1639
2017
Q3 		$1.04M Buy
20,669
+3,700
+22% +$190K 0.01% 1226
2017
Q2 		$925K Buy
16,969
+12,675
+295% +$605K 0.01% 1466
2017
Q1 		$181K Sell
4,294
-1,180
-22% -$50.4K ﹤0.01% 2514
2016
Q4 		$235K Sell
5,474
-9,896
-64% -$402K ﹤0.01% 2237
2016
Q3 		$634K Buy
15,370
+12,720
+480% +$533K 0.01% 1507
2016
Q2 		$106K Sell
2,650
-2,118
-44% -$76.2K ﹤0.01% 2367
2016
Q1 		$161K Buy
+4,768
New +$149K ﹤0.01% 2325
2015
Q4 		– Sell
-4,868
Closed -$145K – 2824
2015
Q3 		$145K Buy
+4,868
New +$152K ﹤0.01% 1640
2015
Q1 		– Sell
-13,793
Closed -$306K – 2779
2014
Q4 		$306K Buy
+13,793
New +$280K ﹤0.01% 2049
2013
Q4 		– Sell
-9,935
Closed -$163K – 2805
2013
Q3 		$163K Buy
+9,935
New +$159K ﹤0.01% 2324

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

SG Americas Securities's IART Position: Q2 2026 in Review

SG Americas Securities increased its Integra LifeSciences (IART) stake by 50% in Q2 2026, buying an estimated $919K and bringing the position to 196,233 shares worth $3.52M. The position accounts for ﹤0.01% of the portfolio, ranked #1246.

SG Americas Securities first reported a position in IART in Q3 2013 and has held it in 41 quarters since. The position peaked at $4.72M in Q4 2025. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • SG Americas Securities held 196,233 shares of Integra LifeSciences worth $3.52M as of Q2 2026.
  • SG Americas Securities bought 65,679 Integra LifeSciences shares in Q2 2026, an estimated $919K.
  • Integra LifeSciences made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1246 holding.
  • SG Americas Securities first reported a position in Integra LifeSciences in Q3 2013 and has held it in 41 quarters since.
  • SG Americas Securities's Integra LifeSciences position peaked at $4.72M in Q4 2025.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.